Global Microneedle Flu Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 91

Published Date: 01 Apr 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Microneedle Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Microneedle Flu Vaccine size is estimated to be xx million in 2021 from USD XX million in 2020, with a change of XX% between 2020 and 2021. The global Microneedle Flu Vaccine market size is expected to grow at a CAGR of XX% for the next five years.

Market segmentation
Microneedle Flu Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Solid Microneedle
    Hollow Microneedle
    Coated Microneedle
    Dissolving Microneedle

Market segment by Application can be divided into
    Influenza A
    Influenza B

The key market players for global Microneedle Flu Vaccine market are listed below:
    Sanofi
    GC Pharma
    Debiotech
    NanoPass Technologies
    Corium International
    Becton Dickinson and Company
    FluGen
    CosMED Pharmaceuticals
    Microdermics and OraSure Technologies

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Microneedle Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Microneedle Flu Vaccine, with price, sales, revenue and global market share of Microneedle Flu Vaccine from 2019 to 2021.
Chapter 3, the Microneedle Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microneedle Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Microneedle Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Microneedle Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Microneedle Flu Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Microneedle Flu Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Solid Microneedle
        1.2.3 Hollow Microneedle
        1.2.4 Coated Microneedle
        1.2.5 Dissolving Microneedle
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Microneedle Flu Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Influenza A
        1.3.3 Influenza B
    1.4 Global Microneedle Flu Vaccine Market Size & Forecast
        1.4.1 Global Microneedle Flu Vaccine Sales in Value (2016-2026))
        1.4.2 Global Microneedle Flu Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Microneedle Flu Vaccine Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Microneedle Flu Vaccine Production Capacity Analysis
        1.5.1 Global Microneedle Flu Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Microneedle Flu Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Microneedle Flu Vaccine Market Drivers
        1.6.2 Microneedle Flu Vaccine Market Restraints
        1.6.3 Microneedle Flu Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Microneedle Flu Vaccine Product and Services
        2.1.4 Sanofi Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 GC Pharma
        2.2.1 GC Pharma Details
        2.2.2 GC Pharma Major Business
        2.2.3 GC Pharma Microneedle Flu Vaccine Product and Services
        2.2.4 GC Pharma Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Debiotech
        2.3.1 Debiotech Details
        2.3.2 Debiotech Major Business
        2.3.3 Debiotech Microneedle Flu Vaccine Product and Services
        2.3.4 Debiotech Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 NanoPass Technologies
        2.4.1 NanoPass Technologies Details
        2.4.2 NanoPass Technologies Major Business
        2.4.3 NanoPass Technologies Microneedle Flu Vaccine Product and Services
        2.4.4 NanoPass Technologies Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Corium International
        2.5.1 Corium International Details
        2.5.2 Corium International Major Business
        2.5.3 Corium International Microneedle Flu Vaccine Product and Services
        2.5.4 Corium International Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Becton Dickinson and Company
        2.6.1 Becton Dickinson and Company Details
        2.6.2 Becton Dickinson and Company Major Business
        2.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
        2.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 FluGen
        2.7.1 FluGen Details
        2.7.2 FluGen Major Business
        2.7.3 FluGen Microneedle Flu Vaccine Product and Services
        2.7.4 FluGen Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 CosMED Pharmaceuticals
        2.8.1 CosMED Pharmaceuticals Details
        2.8.2 CosMED Pharmaceuticals Major Business
        2.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
        2.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Microdermics and OraSure Technologies
        2.9.1 Microdermics and OraSure Technologies Details
        2.9.2 Microdermics and OraSure Technologies Major Business
        2.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
        2.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Microneedle Flu Vaccine Sales by Manufacturer
    3.1 Global Microneedle Flu Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Microneedle Flu Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Microneedle Flu Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Microneedle Flu Vaccine Manufacturer Market Share
        3.4.2 Top 6 Microneedle Flu Vaccine Manufacturer Market Share
    3.5 Global Microneedle Flu Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Microneedle Flu Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Microneedle Flu Vaccine Market Size by Region
        4.1.1 Global Microneedle Flu Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Microneedle Flu Vaccine Revenue by Region (2016-2026)
    4.2 North America Microneedle Flu Vaccine Revenue (2016-2026)
    4.3 Europe Microneedle Flu Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Microneedle Flu Vaccine Revenue (2016-2026)
    4.5 South America Microneedle Flu Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Microneedle Flu Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Microneedle Flu Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Microneedle Flu Vaccine Revenue by Type (2016-2026)
    5.3 Global Microneedle Flu Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Microneedle Flu Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Microneedle Flu Vaccine Revenue by Application (2016-2026)
    6.3 Global Microneedle Flu Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Microneedle Flu Vaccine Sales by Type (2016-2026)
    7.2 North America Microneedle Flu Vaccine Sales by Application (2016-2026)
    7.3 North America Microneedle Flu Vaccine Market Size by Country
        7.3.1 North America Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Microneedle Flu Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Microneedle Flu Vaccine Sales by Type (2016-2026)
    8.2 Europe Microneedle Flu Vaccine Sales by Application (2016-2026)
    8.3 Europe Microneedle Flu Vaccine Market Size by Country
        8.3.1 Europe Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Microneedle Flu Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Microneedle Flu Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Microneedle Flu Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Microneedle Flu Vaccine Market Size by Region
        9.3.1 Asia-Pacific Microneedle Flu Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Microneedle Flu Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Microneedle Flu Vaccine Sales by Type (2016-2026)
    10.2 South America Microneedle Flu Vaccine Sales by Application (2016-2026)
    10.3 South America Microneedle Flu Vaccine Market Size by Country
        10.3.1 South America Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Microneedle Flu Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Microneedle Flu Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Microneedle Flu Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Microneedle Flu Vaccine Market Size by Country
        11.3.1 Middle East & Africa Microneedle Flu Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Microneedle Flu Vaccine Typical Distributors
    12.3 Microneedle Flu Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Microneedle Flu Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Microneedle Flu Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Microneedle Flu Vaccine Product and Services
    Table 6. Sanofi Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. GC Pharma Basic Information, Manufacturing Base and Competitors
    Table 8. GC Pharma Major Business
    Table 9. GC Pharma Microneedle Flu Vaccine Product and Services
    Table 10. GC Pharma Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Debiotech Basic Information, Manufacturing Base and Competitors
    Table 12. Debiotech Major Business
    Table 13. Debiotech Microneedle Flu Vaccine Product and Services
    Table 14. Debiotech Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. NanoPass Technologies Basic Information, Manufacturing Base and Competitors
    Table 16. NanoPass Technologies Major Business
    Table 17. NanoPass Technologies Microneedle Flu Vaccine Product and Services
    Table 18. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Corium International Basic Information, Manufacturing Base and Competitors
    Table 20. Corium International Major Business
    Table 21. Corium International Microneedle Flu Vaccine Product and Services
    Table 22. Corium International Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Becton Dickinson and Company Basic Information, Manufacturing Base and Competitors
    Table 24. Becton Dickinson and Company Major Business
    Table 25. Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
    Table 26. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. FluGen Basic Information, Manufacturing Base and Competitors
    Table 28. FluGen Major Business
    Table 29. FluGen Microneedle Flu Vaccine Product and Services
    Table 30. FluGen Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. CosMED Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 32. CosMED Pharmaceuticals Major Business
    Table 33. CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
    Table 34. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Microdermics and OraSure Technologies Basic Information, Manufacturing Base and Competitors
    Table 36. Microdermics and OraSure Technologies Major Business
    Table 37. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
    Table 38. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Global Microneedle Flu Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
    Table 40. Global Microneedle Flu Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 41. Market Position of Manufacturers in Microneedle Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 42. Global Microneedle Flu Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
    Table 43. Head Office and Microneedle Flu Vaccine Production Site of Key Manufacturer
    Table 44. Microneedle Flu Vaccine New Entrant and Capacity Expansion Plans
    Table 45. Microneedle Flu Vaccine Mergers & Acquisitions in the Past Five Years
    Table 46. Global Microneedle Flu Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 47. Global Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units)
    Table 48. Global Microneedle Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 49. Global Microneedle Flu Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 50. Global Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 51. Global Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)
    Table 52. Global Microneedle Flu Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 53. Global Microneedle Flu Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 54. Global Microneedle Flu Vaccine Price by Type (2016-2021e) & (US$/Unit)
    Table 55. Global Microneedle Flu Vaccine Price by Type (2021-2026) & (US$/Unit)
    Table 56. Global Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 57. Global Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)
    Table 58. Global Microneedle Flu Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 59. Global Microneedle Flu Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 60. Global Microneedle Flu Vaccine Price by Application (2016-2021e) & (US$/Unit)
    Table 61. Global Microneedle Flu Vaccine Price by Application (2021-2026) & (US$/Unit)
    Table 62. North America Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 63. North America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)
    Table 64. North America Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 65. North America Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 66. North America Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 67. North America Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)
    Table 68. North America Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 69. North America Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)
    Table 70. Europe Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 71. Europe Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)
    Table 72. Europe Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 73. Europe Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 74. Europe Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 75. Europe Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)
    Table 76. Europe Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 77. Europe Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)
    Table 78. Asia-Pacific Microneedle Flu Vaccine Sales by Region (2016-2021e) & (K Units)
    Table 79. Asia-Pacific Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units)
    Table 80. Asia-Pacific Microneedle Flu Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 81. Asia-Pacific Microneedle Flu Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 82. Asia-Pacific Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 83. Asia-Pacific Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)
    Table 84. Asia-Pacific Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 85. Asia-Pacific Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)
    Table 86. South America Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 87. South America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)
    Table 88. South America Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 89. South America Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 90. South America Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 91. South America Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)
    Table 92. South America Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 93. South America Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)
    Table 94. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2016-2021e) & (K Units)
    Table 95. Middle East & Africa Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units)
    Table 96. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 97. Middle East & Africa Microneedle Flu Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 98. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2016-2021e) & (K Units)
    Table 99. Middle East & Africa Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units)
    Table 100. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2016-2021e) & (K Units)
    Table 101. Middle East & Africa Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units)
    Table 102. Direct Channel Pros & Cons
    Table 103. Indirect Channel Pros & Cons
    Table 104. Microneedle Flu Vaccine Typical Distributors
    Table 105. Microneedle Flu Vaccine Typical Customers
List of Figures
    Figure 1. Microneedle Flu Vaccine Picture
    Figure 2. Global Microneedle Flu Vaccine Sales Market Share by Type in 2020
    Figure 3. Solid Microneedle
    Figure 4. Hollow Microneedle
    Figure 5. Coated Microneedle
    Figure 6. Dissolving Microneedle
    Figure 7. Global Microneedle Flu Vaccine Sales Market Share by Application in 2020
    Figure 8. Influenza A
    Figure 9. Influenza B
    Figure 10. Global Microneedle Flu Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 11. Global Microneedle Flu Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Microneedle Flu Vaccine Sales (2016-2026) & (K Units)
    Figure 13. Global Microneedle Flu Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 14. Global Microneedle Flu Vaccine Production Capacity (2016-2026) & (K Units)
    Figure 15. Global Microneedle Flu Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 16. Microneedle Flu Vaccine Market Drivers
    Figure 17. Microneedle Flu Vaccine Market Restraints
    Figure 18. Microneedle Flu Vaccine Market Trends
    Figure 19. Global Microneedle Flu Vaccine Sales Market Share by Manufacturer in 2020
    Figure 20. Global Microneedle Flu Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 21. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 22. Top 3 Microneedle Flu Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 23. Top 6 Microneedle Flu Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 24. Global Microneedle Flu Vaccine Sales Market Share by Region (2016-2026)
    Figure 25. Global Microneedle Flu Vaccine Revenue Market Share by Region (2016-2026)
    Figure 26. North America Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)
    Figure 27. Europe Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. Asia-Pacific Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. South America Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)
    Figure 30. Middle East & Africa Microneedle Flu Vaccine Revenue (2016-2026) & (USD Million)
    Figure 31. Global Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)
    Figure 32. Global Microneedle Flu Vaccine Revenue Market Share by Type (2016-2026)
    Figure 33. Global Microneedle Flu Vaccine Price by Type (2016-2026) & (US$/Unit)
    Figure 34. Global Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)
    Figure 35. Global Microneedle Flu Vaccine Revenue Market Share by Application (2016-2026)
    Figure 36. Global Microneedle Flu Vaccine Price by Application (2016-2026) & (US$/Unit)
    Figure 37. North America Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)
    Figure 38. North America Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)
    Figure 39. North America Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)
    Figure 40. North America Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)
    Figure 41. United States Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Canada Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Mexico Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Europe Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)
    Figure 45. Europe Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)
    Figure 46. Europe Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)
    Figure 47. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)
    Figure 48. Germany Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. France Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. United Kingdom Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Russia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Italy Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Asia-Pacific Microneedle Flu Vaccine Sales Market Share by Region (2016-2026)
    Figure 54. Asia-Pacific Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)
    Figure 55. Asia-Pacific Microneedle Flu Vaccine Sales Market Share by Region (2016-2026)
    Figure 56. Asia-Pacific Microneedle Flu Vaccine Revenue Market Share by Region (2016-2026)
    Figure 57. China Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Japan Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Korea Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. India Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Southeast Asia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Australia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. South America Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)
    Figure 64. South America Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)
    Figure 65. South America Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)
    Figure 66. South America Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)
    Figure 67. Brazil Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Argentina Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Type (2016-2026)
    Figure 70. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Application (2016-2026)
    Figure 71. Middle East & Africa Microneedle Flu Vaccine Sales Market Share by Country (2016-2026)
    Figure 72. Middle East & Africa Microneedle Flu Vaccine Revenue Market Share by Country (2016-2026)
    Figure 73. Turkey Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Egypt Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Saudi Arabia Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. South Africa Microneedle Flu Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Sales Channel: Direct Channel vs Indirect Channel
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies

Related Reports

Global Microneedle Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Microneedle Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022

date Pharma & Healthcare

The Microneedle Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2023-2029

date 23 Jan 2023

date Pharma & Healthcare

The global Microneedle Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Microneedle Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Microneedle Flu Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.

Global Microneedle Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Microneedle Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Microneedle Flu Vaccine market size was valued at USD 1463.2 million in 2023 and is forecast to a readjusted size of USD 2095.3 million by 2030 with a CAGR of 5.3% during review period.

Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2024-2030

Global Microneedle Flu Vaccine Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Microneedle Flu Vaccine market size is expected to reach $ 2095.3 million by 2030, rising at a market growth of 5.3% CAGR during the forecast period (2024-2030).

Product Tags

microneedle flu vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>